Tag: near-patient molecular solutions market size

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Near-Patient Molecular Solutions Market Revenue Outlook: What CAGR Is Expected Through 2030?

The market for molecular solutions situated close to patients has experienced robust expansion historically and is projected to continue this upward trajectory. Forecasts indicate a rise from $4.54 billion in 2025 to $4.99 billion in 2026, reflecting a compound annual growth rate of 9.8%. Key factors driving this growth in the preceding period include the broader implementation of molecular diagnostic methodologies, an increasing need for swift test result delivery, the shift towards decentralized laboratory operations, a surge in diagnostic procedures performed in outpatient environments, and the uptake of mobile diagnostic devices.

The market for molecular solutions delivered close to the patient is poised for substantial expansion over the coming years, projecting a market size of $7.17 billion by 2030, driven by a compound annual growth rate of 9.5%. This anticipated growth throughout the forecast period is fueled by several key factors, including a heightened emphasis on personalized medicine approaches, a growing preference for at-home and remote testing options, continuous innovation in compact molecular testing technologies, the broadening scope of infectious disease monitoring, and the seamless incorporation of these solutions into broader digital health frameworks. Key developments on the horizon involve a greater acceptance of point-of-care molecular diagnostic instruments, an escalating need for swift identification of infectious diseases, the increasing use of portable PCR systems, the development of distributed diagnostic networks, and an intensified commitment to ensuring the precision of testing performed near the patient.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30333&type=smp

Near-Patient Molecular Solutions Market Development Factors: Which Trends Are Supporting Demand?

The burgeoning requirement for diagnostic tools used at home is anticipated to fuel the expansion of the near-patient molecular solutions market. These near-patient molecular solutions play a crucial role in empowering these home-based point-of-care devices by offering precise, swift, and easily transportable molecular diagnostic capabilities that can be dependably employed outside of conventional laboratory environments. Such devices, designed for operation by patients or untrained individuals within their residences, facilitate sample collection, analysis, or result interpretation away from traditional central laboratory facilities and in close proximity to where care is administered. The increasing consumer inclination towards health monitoring that is convenient, fast, and readily available outside of formal medical establishments is contributing to the rising demand for these home-use point-of-care systems. Illustrating this trend, a February 2023 update from the US Food & Drug Administration (FDA) indicated a significant number of Emergency Use Authorizations (EUAs) for at-home testing, encompassing one for a molecular prescription test, two for antigen prescription tests, four for over-the-counter (OTC) molecular tests, and twenty-six for OTC antigen tests, thereby underscoring the expanding market for home-based diagnostic solutions and consequently, the near-patient molecular solutions market.

Near-Patient Molecular Solutions Market Categorization By Product Type And Application

The near-patient molecular solutions market covered in this report is segmented –

1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

Near-Patient Molecular Solutions Market Transformation Trends: Which Innovations Are Driving Change?

Key players in the near-patient molecular solutions sector are prioritizing the integration of innovative technologies, particularly isothermal nucleic acid amplification, to elevate testing speed, mobility, and the precision of diagnoses. This sophisticated molecular diagnostic method amplifies specific DNA or RNA segments at a stable temperature, bypassing the thermal cycling requirement of traditional PCR, which facilitates swift, highly sensitive, and easily transportable molecular analyses. As an illustration, June 2023 saw Cue Health Inc., a US firm devoted to molecular diagnostics, secure FDA clearance for its Cue COVID-19 Molecular Test. This test utilizes isothermal amplification and is engineered for SARS-CoV-2 RNA detection both at home and at the point of care. The device comprises a disposable cartridge, a Bluetooth-linked reader, and a mobile application that provides user instructions and delivers molecular test outcomes in approximately 20 minutes. Consequently, the Cue COVID-19 molecular test expands the availability of precise molecular diagnostics, shortens the time to results, and empowers timely health choices beyond conventional laboratory settings.

Near-Patient Molecular Solutions Market Company Landscape And Strategic Competition

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

Access The Complete Near-Patient Molecular Solutions Market Report:

https://www.thebusinessresearchcompany.com/report/global-near-patient-molecular-solutions-market-report

Near-Patient Molecular Solutions Market Largest Region By Revenue And Market Share

North Americawas the largest region in the near-patient molecular solutions market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Value Of The Near-Patient Molecular Solutions Market Projected To Expand During 2026–2030?

The near-patient molecular solutions market has demonstrated robust expansion over recent years. It is projected to grow from $4.54 billion in 2025 to $4.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. The historic growth in this market can be ascribed to the increasing use of molecular diagnostic techniques, the need for faster test results, the decentralization of laboratory services, the development of outpatient diagnostic environments, and the integration of portable diagnostic instruments.

The near-patient molecular solutions market is projected to experience substantial expansion in the coming years. By 2030, this market is forecast to reach $7.17 billion, demonstrating a compound annual growth rate (CAGR) of 9.5%. This anticipated growth is primarily driven by several factors, including an intensified focus on personalized medicine, a growing need for home and remote testing options, innovations in miniaturized molecular platforms, the broadening scope of infectious disease surveillance, and better integration with digital health ecosystems. Key trends expected during this period involve the wider adoption of point-of-care molecular testing devices, an escalating requirement for swift infectious disease diagnostics, the increasing incorporation of portable PCR platforms, the development of decentralized diagnostic infrastructure, and a heightened emphasis on the precision of near-patient testing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30333&type=smp

Which Growth Drivers Are Expected To Support The Near-Patient Molecular Solutions Market Forward?

The increasing need for home-use point-of-care devices is anticipated to drive the expansion of the near patient molecular solutions market in the future. These home-based point-of-care devices are diagnostic tools utilized by individuals or non-professionals at or close to their residences, facilitating sample gathering, analysis, or result interpretation away from a standard central laboratory environment and directly at the point of care. The heightened demand for such devices stems from consumers’ growing preference for health monitoring that is convenient, quick, and readily available beyond conventional medical facilities. Near-patient molecular solutions contribute to home-based point-of-care devices by offering precise, fast, and portable molecular diagnostic capabilities that are dependable for use outside typical laboratory environments. As an illustration, in February 2023, the US Food & Drug Administration (FDA), a US-based government agency, noted in its 2023 COVID-19 testing update that authorizations included one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. Consequently, the escalating demand for home-based point-of-care devices is fueling the expansion of the near-patient molecular solutions market.

Which Segment-Based Categories Are Covered In The Near-Patient Molecular Solutions Market?

The near-patient molecular solutions market covered in this report is segmented –

1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

Which Trends Are Guiding The Development Of The Near-Patient Molecular Solutions Market?

Leading firms within the natural insect repellents market are concentrating on creating novel formulations, like mosquito-repellent sprays, to offer instant defense against mosquito bites, thereby aiding in the reduction of insect-borne disease risks. These sprays are either aerosol or liquid applications formulated to deter mosquitoes from biting through the application of a protective layer of active components onto the skin or adjacent surfaces. An example is Diptyque, a France-based luxury fragrance brand, which introduced a body spray with mosquito-repellent qualities in June 2023. This limited-edition perfuming summer body spray combines utility with indulgence, presenting a distinct blend of essential oils recognized for their mosquito-repellent attributes, such as lemongrass, geranium, and lemon eucalyptus. These oils are smoothly integrated with the invigorating, aromatic notes of neroli and orange blossom, yielding a vibrant and floral scent that simultaneously assists in mosquito protection.

Which Organizations Are Involved In The Near-Patient Molecular Solutions Market?

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

Access The Complete Near-Patient Molecular Solutions Market Report:

https://www.thebusinessresearchcompany.com/report/global-near-patient-molecular-solutions-market-report

Which Regional Market Leads The Near-Patient Molecular Solutions Market?

North America was the largest region in the near-patient molecular solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Near-Patient Molecular Solutions Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=30333&type=smp

Browse Through More Reports Similar to the Global Near-Patient Molecular Solutions Market 2026, By The Business Research Company

Household Insecticides Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report

Edible Insects Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/edible-insects-global-market-report

Tick Repellent Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/tick-repellent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Near-Patient Molecular Solutions Market Expected To Change From 2026 To 2030?

The near-patient molecular solutions market has demonstrated significant expansion in recent years. Its size is forecast to rise from $4.54 billion in 2025 to $4.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. The driving forces behind this past growth include the broader adoption of molecular diagnostic techniques, the requirement for quick test processing times, the distribution of laboratory services, the expansion of diagnostic settings outside of hospitals, and the use of portable diagnostic devices.

The near-patient molecular solutions market size is expected to undergo significant expansion in the coming years, with projections indicating it will reach $7.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.5%. This growth during the forecast period is primarily attributed to a heightened focus on personalized medicine, increasing demand for home and remote testing solutions, advancements in miniaturized molecular platforms, the expansion of infectious disease surveillance, and greater integration with digital health ecosystems. Major trends foreseen for the same period include a growing adoption of point-of-care molecular testing devices, an escalating demand for rapid infectious disease diagnostics, the increasing incorporation of portable PCR platforms, the development of decentralized diagnostic infrastructure, and an enhanced emphasis on the accuracy of near-patient testing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30333&type=smp

What Significant Factors Are Influencing The Near-Patient Molecular Solutions Market Expansion?

The expansion of the near patient molecular solutions market is anticipated to be fueled by the increasing need for home-based point-of-care devices. These devices are diagnostic systems used by individuals or non-lab personnel at or close to their residences, facilitating sample gathering, analysis, or result interpretation away from a traditional central laboratory and near the point of care. The increasing demand for home-based point-of-care devices stems from consumers’ growing preference for health monitoring that is convenient, fast, and easily accessible beyond conventional healthcare environments. Near-patient molecular solutions aid these home-based devices by offering precise, swift, and portable molecular diagnostics suitable for dependable use outside standard laboratory environments. An illustration of this trend is the report from the US Food & Drug Administration (FDA), a US-based government agency, in its 2023 COVID-19 testing update in February 2023. This report indicated the presence of one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. Consequently, the increasing need for home-based point-of-care devices is a significant factor boosting the expansion of the near patient molecular solutions market.

How Is The Near-Patient Molecular Solutions Market Segmented Across Different Segment Categories?

The near-patient molecular solutions market covered in this report is segmented –

1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

What Trends Are Affecting The Direction Of The Near-Patient Molecular Solutions Market?

Leading companies operating within the near-patient molecular solutions market are focusing on integrating technological advancements, such as isothermal nucleic acid amplification, to improve testing efficiency, portability, and diagnostic accuracy. Isothermal nucleic acid amplification is an advanced molecular diagnostic technology that amplifies target nucleic acid sequences at a consistent temperature, removing the necessity for thermal cycling present in conventional polymerase chain reaction (PCR), thereby enabling fast, sensitive, and compact molecular testing. For instance, in June 2023, Cue Health Inc., a US-based healthcare technology company specializing in molecular diagnostics, received FDA marketing authorization for its Cue COVID-19 Molecular Test. This isothermal amplification-based diagnostic device is designed for the at-home and point-of-care detection of SARS-CoV-2 RNA. The system includes a single-use cartridge, a Bluetooth-enabled reader, and a mobile app interface that guides users through the testing process and provides molecular results in about 20 minutes. The Cue COVID-19 molecular test enhances access to accurate molecular-level diagnostics, shortens turnaround time, and supports real-time health decision-making outside of traditional laboratory environments.

Which Organizations Play A Role In The Near-Patient Molecular Solutions Market Landscape?

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

Get The Full Near-Patient Molecular Solutions Market Report:

https://www.thebusinessresearchcompany.com/report/global-near-patient-molecular-solutions-market-report

Which Region Is The Leading Market For The Near-Patient Molecular Solutions Market?

North America was the largest region in the near-patient molecular solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Near-Patient Molecular Solutions Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-near-patient-molecular-solutions-market-report

Browse Through More Reports Similar to the Global Near-Patient Molecular Solutions Market 2026, By The Business Research Company

Household Insecticides Market Report 2026

https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report

Edible Insects Market Report

https://www.thebusinessresearchcompany.com/report/edible-insects-global-market-report

Tick Repellent Market Report

https://www.thebusinessresearchcompany.com/report/tick-repellent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Near-Patient Molecular Solutions Market In 2026 And What Value Is Projected For 2030?

The near-patient molecular solutions market has exhibited significant expansion in recent years. This market is expected to reach $4.99 billion in 2026 from $4.54 billion in 2025, progressing at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to the historical growth include the broader application of molecular diagnostic techniques, the necessity for quick test result delivery, the shift towards decentralized laboratory services, an increase in outpatient diagnostic environments, and the adoption of portable diagnostic instruments.

The near-patient molecular solutions market is anticipated to experience substantial expansion in the coming years. It is projected to reach $7.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This growth in the forecast period is primarily driven by an increased focus on personalized medicine, a rising demand for home and remote testing solutions, technological advancements in miniaturized molecular platforms, the expansion of infectious disease surveillance, and better integration with digital health ecosystems. Significant trends during this period include a greater adoption of point-of-care molecular testing devices, an escalating need for rapid infectious disease diagnostics, the growing integration of portable PCR platforms, the expansion of decentralized diagnostic infrastructure, and an enhanced focus on near-patient testing accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30333&type=smp

What Major Drivers Are Influencing Demand In The Near-Patient Molecular Solutions Market?

The increasing need for home-based point-of-care devices is anticipated to propel the expansion of the near patient molecular solutions market in the coming years. These home-based point-of-care devices are diagnostic testing systems that allow patients or non-laboratory users to operate them at or near their homes, facilitating sample collection, analysis, or result reading outside a conventional central laboratory setting and close to the point of care. The rising demand for these devices is primarily driven by a growing consumer preference for convenient, rapid, and accessible health monitoring solutions outside traditional healthcare environments. Near-patient molecular solutions enhance home-based point-of-care devices by providing accurate, rapid, and portable molecular diagnostics that can be reliably utilized beyond conventional laboratory settings. For instance, in February 2023, the US Food & Drug Administration (FDA), a US-based government agency, reported in its 2023 COVID-19 testing update that there was one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. Hence, the increasing demand for home-based point-of-care devices is fueling the growth of the near-patient molecular solutions market.

What Are The Key Segments Of The Near-Patient Molecular Solutions Market?

The near-patient molecular solutions market covered in this report is segmented –

1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

How Are Trends Transforming The Near-Patient Molecular Solutions Market Landscape?

Leading companies in the near-patient molecular solutions market are concentrating on integrating technological advancements, such as isothermal nucleic acid amplification, to improve testing efficiency, portability, and diagnostic accuracy. This sophisticated molecular diagnostic method amplifies target nucleic acid sequences at a constant temperature, removing the need for thermal cycling typically found in conventional polymerase chain reaction (PCR), thus enabling quick, sensitive, and compact molecular testing. As an example, in June 2023, Cue Health Inc., a US-based healthcare technology company focused on molecular diagnostics, secured FDA marketing authorization for the Cue COVID-19 Molecular Test. This device, based on isothermal amplification, is designed for the detection of SARS-CoV-2 RNA at home and at the point of care. The system includes a single-use cartridge, a Bluetooth-enabled reader, and a mobile app interface that walks users through the test and delivers molecular results in about 20 minutes. The Cue COVID-19 molecular test boosts access to accurate molecular-level diagnostics, cuts down turnaround time, and supports real-time health decision-making outside traditional laboratory environments.

Who Are The Leading Companies Operating In The Near-Patient Molecular Solutions Market?

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

Read the full near-patient molecular solutions market report here:

https://www.thebusinessresearchcompany.com/report/global-near-patient-molecular-solutions-market-report

Which Region Shows The Strongest Potential For Future Growth In The Near-Patient Molecular Solutions Market?

North America was the largest region in the near-patient molecular solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Near-Patient Molecular Solutions Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30333&type=smp

Browse Through More Reports Similar to the Global Near-Patient Molecular Solutions Market 2026, By The Business Research Company

Household Insecticides Global Market Report

https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report

Edible Insects Global Market Report

https://www.thebusinessresearchcompany.com/report/edible-insects-global-market-report

Tick Repellent Global Market Report

https://www.thebusinessresearchcompany.com/report/tick-repellent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model